Inside Stanford V. Roche

Law360, New York (June 22, 2011, 3:57 PM EDT) -- The U.S. Supreme Court's June 6, 2011, decision in Board of Trustees of the Leland Stanford Junior University v. Roche Molecular Systems Inc. addressed whether a research institution’s use of federal funding, thereby implicating the Bayh-Dole Act, displaces the traditional U.S. patent law principle providing that ownership vests in the inventor.


In the early 1980s, a small company called Cetus developed methods to quantify blood-borne HIV levels known as polymerase chain reaction (PCR). In 1988, Cetus contracted with Stanford University’s Department of Infectious Diseases to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.